Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Antengene Corporation

Clinical trials sponsored by Antengene Corporation, explained in plain language.

Now part of Antengene Corporation Limited 6996 HKEX

A biopharmaceutical company developing oncology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1 Terminated 1

Can adding selinexor to standard therapy extend remission in Hard-to-Treat myeloma?

Disease control Completed

This phase III trial is testing whether adding selinexor to a standard two-drug regimen (bortezomib and dexamethasone) can help people with relapsed or refractory multiple myeloma—a blood cancer that has returned or stopped responding to treatment. About 154 adults with measurabl…

Phase: PHASE3 • Sponsor: Antengene Corporation • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC